Tirzepatide (LY3298176) represents a breakthrough in peptide-based metabolic research. This synthetic peptide acts as a dual agonist for both GLP-1 and GIP receptors, making it particularly interesting for studies related to glucose metabolism and weight management.
With a molecular formula of C225H348N48O68 and molecular weight of 4813, Tirzepatide demonstrates superior stability and biological activity. The peptide's unique mechanism of action simultaneously targets multiple pathways involved in energy homeostasis, offering researchers a valuable tool for metabolic studies.
Our facility produces Tirzepatide under strict GMP conditions, ensuring batch-to-batch consistency and purity exceeding 99% as verified by HPLC analysis. The white powder form is stable when stored properly (-20°C for long term) and shows excellent solubility in DMSO for research applications.
Important Note: This product is intended for research purposes only and not for human consumption. Proper handling procedures should be followed by qualified researchers in laboratory settings.